results of a first-line study of pembrolizumab in advanced urothelial cancer
Published 7 years ago • 122 plays • Length 2:15Download video MP4
Download video MP3
Similar videos
-
1:58
results for first-line pembrolizumab in advanced urothelial carcinoma
-
1:45
results for pembrolizumab as a first-line therapy for advanced urothelial carcinoma
-
2:41
leap-011: exploring first-line pembrolizumab lenvatinib for advanced urothelial carcinoma
-
6:02
ev-103: ev pembrolizumab as a promising first-line option for urothelial carcinoma
-
0:51
impact of the keynote-045 study comparing pembrolizumab and chemotherapy in bladder cancer
-
3:21
esmo 2020 highlights on pembrolizumab as 1st line therapy for auc: the keynote-361 study
-
1:36
pembrolizumab in urothelial cancer
-
46:42
imaging and radiation lunch & learn | wilmot cancer institute
-
4:32
first-line regorafenib 80mg/day with pembrolizumab in advanced hcc
-
0:16
imvigor 210 results in metastatic urothelial carcinoma
-
2:41
firstline pembrolizumab for metastatic urothelial cancer
-
1:23
how effective is pembrolizumab in cisplatin-ineligible bladder cancer? results from keynote-052
-
16:37
state of the art lecture - developments in metastatic urothelial cancer
-
1:54
two-year follow-up results from keynote-045 study in urothelial carcinoma
-
2:12
real-world study of atezolizumab vs. pembrolizumab for advanced/metastatic uc
-
0:58
significance of keynote-045 trial of pembrolizumab vs chemotherapy in urothelial carcinoma
-
2:43
pembrolizumab: defining standards of care in urothelial cancer
-
3:32
value of pd-l1 testing in metastatic urothelial cancer
-
1:44
efficacy and biomarker results for pembrolizumab in soft tissue and bone sarcomas